2 models fit CVR Energy Inc. Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver65
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionCVR Energy Inc. Common Stock (CVI)
Fair value (2 models)
$25.92
ACCE price target
$42.00
Rating
Overvalued
Horizon
12 months
Fair value published on 18 Oct 2026, 00:00 CEST; previously $26.36 since 14 Oct 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Price used: $58.16 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, Graham number, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
124.4% above
-55.4% to fair value
ACCE score
60
out of 100
Analysts
0% buy
6 covering
P/E
88.1x
forward 12.8x
1-year return
+48.6%
Dividend yield
0.68%
CVR Energy Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
CVR Energy runs two petroleum refineries (Coffeyville, Kansas and Wynnewood, Oklahoma) and a nitrogen fertilizer business that makes ammonia and UAN, along with a majority stake in CVR Partners and its Icahn-linked renewable diesel and RINs exposure. The fertilizer segment is the structural piece: its low-cost, pet-coke-fed nitrogen plant sits in the middle of the US corn belt, which gives it cost and logistics advantages over imported product. Revenue grew 55.5% over the trailing period, and at a 2.9% operating margin the earnings base is thin, so the valuation of 90.7 times trailing and 40.5 times forward earnings reflects a recovery being priced in rather than current profitability. A 24.3% return on equity says the capital base is working, but a 10.9% gross margin leaves little room for crack-spread or fertilizer-price swings to go the wrong way. The name is worth a deeper look if the forward multiple is credible, which turns on refining margins holding up through the next two quarters and on whether the fertilizer cycle keeps supporting nitrogen prices. The score of 60 and the absence of index membership mean it is a small-cap, cyclical, leveraged proposition, and the work to do is on the crack spread and nitrogen pricing assumptions rather than on the headline growth figure.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Earnings collapsing despite revenue growth
Revenue is up 55.5% year over year, yet earnings fell 68.1% and net margin is only +0.8%. Growth is not converting into profit.
high
Negative free cash flow with heavy leverage
Free cash flow is -$41,000,000 and debt to equity sits at 2.51. The balance sheet has little room to absorb a downturn.
moderate
Elevated short interest
Short interest stands at 19.1% of shares. Heavy short positioning often signals doubt about the earnings outlook and can add volatility.
moderate
Trading far above valuation models
The price trades 124.4% above the model fair value of $25.92, and 38.5% above the ACCE price target of $42.00. Current pricing assumes a recovery the models do not.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 55.5% year over year, far above the 12.8% yearly average over five years.
Return on equity of 24.3% shows the company turns shareholder capital into profit at a strong rate.
The latest quarter beat expectations, with earnings per share of 0.34 against 0.18 expected, a surprise of 88.9%.
Why it could disappoint
The stock trades 124.4% above the model fair value of $25.92, and only 2 of 4 valuation models feed that figure.
Free cash flow over the last twelve months was negative at -$41M, so the business is not yet generating cash for owners.
Debt to equity of 2.51 and a 0.8% net margin leave little cushion if refining margins weaken.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 3, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where CVI's valuation models land
Price
$58.16
Model fair value
$25.92
Model range
$21.12 to $30.73
Fair value $25.92
Price $58.16
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores